Paid Clinical Trials Minneapolis
Discover 1,058 paid clinical trials in Minneapolis, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
FT825/ONO-8250 & Monoclonal AntibodiesFT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
Sponsor:
Fate Therapeutics
Location:
Code:
NCT06241456
Conditions
Advanced Solid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
FT825
Fludarabine
Cyclophosphamide
Bendamustine
Docetaxel
NutritionStrength and Muscle Related Outcomes for Nutrition and Lung Function in CF
Sponsor:
Jaeb Center for Health Research
Location:
Code:
NCT05639556
Conditions
Cystic Fibrosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BMI and lean mass index from DXA
Anthropometric Measurements
Hand-grip strength
Six-minute walk Test
Sit-to-Stand Test
Alisertib & Endocrine TherapyA Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Sponsor:
Puma Biotechnology, Inc.
Location:
Code:
NCT06369285
Conditions
Hormone Receptor Positive HER-2 Negative Breast Cancer
Metastatic Breast Cancer
Recurrent Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Alisertib
Endocrine therapy
Thrombectomy PlatformStrokeNet Thrombectomy Endovascular Platform
Sponsor:
Medical University of South Carolina
Location:
Code:
NCT06289985
Conditions
Ischemic Stroke
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Endovascular thrombectomy with any FDA-approved category POL or NRY device
Medical Management
PF-07220060 with LetrozoleStudy of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Sponsor:
Pfizer
Location:
Code:
NCT06760637
Conditions
Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
PF-07220060
letrozole
abemaciclib
palbociclib
ribociclib
Interested in new trials?
Get alerts for new trials in your area by subscribing now
IVUS Guided TreatmentIMPact on Revascularization Outcomes of IVUS Guided Treatment of Complex Lesions and Economic Impact
Sponsor:
Medstar Health Research Institute
Location:
Code:
NCT04221815
Conditions
Atherosclerosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Eagle Eye Platinum digital IVUS catheter with optional SyncVision
Resolute Onyx Drug Eluting Stent
Onyx Frontier Drug Eluting Stent
Onyx TruStar Drug Eluting Stent
Onyx TruCor Drug Eluting Stent
EVAR vs. ESARComparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck
Sponsor:
Rijnstate Hospital
Location:
Code:
NCT05484115
Conditions
Aortic Aneurysm, Abdominal
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
endovascular aneurysm repair (EVAR) using the Endurant II/IIs stent graft system
endosuture aneurysm repair (ESAR) using Heli-FX EndoAnchor system
NXC-201 CAR-TStudy of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis
Sponsor:
Nexcella Inc.
Location:
Code:
NCT06097832
Conditions
Light Chain (AL) Amyloidosis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
NXC-201 CAR-T
RMT & Durvalumab, ChemoRMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
Sponsor:
Masonic Cancer Center, University of Minnesota
Location:
Code:
NCT04105270
Conditions
Adenocarcinoma of Lung
Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Oral Restorative Microbiota Therapy (RMT) Capsules
Durvalumab 1500 mg IV
Cisplatin/pemetrexed or Carboplatin/pemetrexed
Placebo
Observational StudyRacial and Economic Disparities and Unmet Needs in Patients With Severe Aortic Valvular Disease
Sponsor:
Minneapolis Heart Institute Foundation
Location:
Code:
NCT04525937
Conditions
Disparities in Treatment of Aortic Valve Stenosis
Aortic Valve Stenosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Patient Questionnaire
Provider Questionnaire